MTG > Metagame Legacy > deck Sultai Doomsday
About Legacy Sultai Doomsday
Belonging to the metagame from Legacy, Sultai Doomsday is a deck with the following key cards: Force of Will, Dark Ritual, Brainstorm, Ponder, Doomsday, Underground Sea, Polluted Delta, Lotus Petal, with an overall win percentage of 53.8% in 26 games in the last 6 months. The deck performances better against Worldgorger Dragon Combo and 5c Zenith and worst against 5c Zenith and Dimir Omni-Tell. In recent appearances clan made 19º at Legacy Challenge 64 and kabloom made 48º at Legacy Challenge 64.
Main Deck cards Sultai Doomsday
Sideboard cards Sultai Doomsday
Strategy
Sultai Doomsday is a deck in Legacy that revolves around the powerful combo of Doomsday and Thassa's Oracle. The main strategy of the deck is to use cards like Brainstorm, Ponder, and Personal Tutor to set up a winning pile with Doomsday, Thassa's Oracle, and the necessary cards to win the game. The deck aims to win by casting Doomsday, stacking the deck with Thassa's Oracle and the needed cards, and then drawing the Oracle to win the game on the spot. Good points of Sultai Doomsday include its ability to win the game quickly and efficiently once the combo is set up. The deck is also resilient to disruption due to cards like Force of Will, Force of Negation, and Duress to protect the combo. Additionally, the deck has access to powerful disruption in Thoughtseize and Leyline of the Void to interact with the opponent's game plan. However, Sultai Doomsday can be vulnerable to aggressive strategies that can disrupt its game plan before it can set up the combo. The deck also requires precise sequencing and timing to set up the Doomsday pile correctly, making it a challenging deck to pilot effectively. Overall, Sultai Doomsday is a powerful and combo-oriented deck in Legacy that can be rewarding to play for experienced pilots who enjoy intricate gameplay and high-risk, high-reward strategies.
Legacy deck Sultai Doomsday: Last winning deck
Recent decklists
Decklist
Pilot
Date
Tournament
— Comments0
Be the first to comment